logo
  

Apollo To Take Minority Equity Interest In Sofinnova; To Invest 1 Bln Euros

Apollo Global Management, Inc. (APO) and Sofinnova Partners, a European life sciences venture capital firm, announced Monday a long-term strategic and financial partnership.

Under the agreement, Apollo will take a minority equity interest in Sofinnova and commit up to 1 billion euros of managed capital to its investment funds. This strategic partnership is poised to significantly accelerate Sofinnova's growth.

For Apollo, the investment will meaningfully increase its presence in life sciences and contribute to its growth ecosystem of partners that bring specialized knowledge and networks to its integrated platform.

Together, Sofinnova and Apollo will offer entrepreneurs a more comprehensive range of capital solutions to help bring new therapeutic and biotechnology-based solutions to the market.

The commitment to invest up to 1 billion euros in Sofinnova vehicles, including future strategies the two firms may co-develop, will support companies at the forefront of life sciences innovation.

Sofinnova will also gain access to Apollo's global investment platform spanning credit, equities, real estate and other asset classes, as well as its far-reaching networks and capital markets expertise.

Sofinnova will continue to operate from its Paris headquarters as an independent organization.

The transaction is subject to customary closing conditions, including prior authorization by the French Autorité des Marchés Financiers, and is expected to close in the second half of 2022.

Upon close, Neil Mehta, Partner and Global Head of Strategy at Apollo, will join Sofinnova's Board of Directors.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The US Centers for Disease Control and Prevention or CDC has ended recommendations for social distancing and quarantine with a view to minimize covid-19's impact on persons, communities, and health care systems. The agency also ended recommendation for test-to-stay in schools, CNN noted. Healthcare major Johnson & Johnson, which is in the middle of a talcum powder fiasco, said it is discontinuing talc-based JOHNSON'S Baby Powder globally in 2023. The company plans to transition to an all cornstarch-based baby powder portfolio. According to the company, the commercial decision to use cornstarch in all its baby powder products was made after conducting an assessment of its portfolio Walt Disney's streaming service Disney+ is rolling out its much-anticipated new ad-supported subscription plan for Disney+ in the U.S. as part of its bid to stem the loss and make its streaming business profitable after the services posted a hefty operating loss of more than $1 billion in the third quarter. It is also raising pricing for its bundled subscription plans with Hulu, ESPN+ and live TV.
RELATED NEWS
Follow RTT